Botanical species · safety record

Saraca asoca

The EFSA Compendium of Botanicals holds 10 constituent measurements and 1 adverse-effect record for Saraca asoca. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Saraca asoca (Roxb.) Willd.

10Constituent measurements

1Safety records

8Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alpha-thujone	Bark	Solvent extraction	—	Unspecified	Resolve DOI
Gallic acid	Bark	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Lignans	Live plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Lignans	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Methyl salicylate	Flower	Essential oil	9.5 Percent	GC-MS	Resolve DOI
Tannins	Bark	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Anthraquinones	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Salicylates	Seed	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Saponins	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Pulmonary and cardiac	Cardiovascular / haematological	Bark	Solvent extraction	Rat (as animal)	Short-term toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Mukhopadhyay, M.K., Nath, D. Phytochemical screening and toxicity study of Saraca asoca bark methanolic extract. International journal of phytomedicine, 2011, vol. 3, no. 4, p. 498-505.
Joshi, R.K. E,E-alpha-Farnesene rich essential oil of Saraca asoca (Roxb.) Wilde flower. Natural product research, 2015. DOI
Mittal, Ashwani., Kadyan, Preeti., Gahlaut, Anjum., Dabur, Rajesh. Nontargeted Identification of the Phenolic and Other Compounds of Saraca asoca by High Performance Liquid Chromatography-Positive Electrospray Ionization and Quadrupole Time-of-Flight Mass Spectrometry.. ISRN pharmaceutics, 2013, vol. 2013, p. 293935-293935. DOI
Gupta Mradu., Sasmal Saumyakanti., Mukherjee Arup. Therapeutic Effects of Acetone Extract of Saraca asoca Seeds on Rats with Adjuvant-Induced Arthritis via Attenuating Inflammatory Responses. Isrn rheumatology, 2014.
Aeri, Vidhu., Mishra, Shikha. Evaluation of Pre- and Post-Fermented Aqueous Decoction of Saraca asoca by High-Performance Thin-Layer Chromatography . Jpc-journal of planar chromatography-modern tlc, 2015, vol. 28, no. 1, p. 36-41. DOI
Ahmed, F., Sadhu, S.K., Ishibashi, M. Search for bioactive natural products from medicinal plants of Bangladesh. Journal of natural medicines, 2010, vol. 64, no. 4, p. 393-401. DOI
Singh, Arundhati., Singh, V. K. Molluscicidal activity of Saraca asoca and Thuja orientalis against the fresh water snail Lymnaea acuminata . Veterinary parasitology, 2009, vol. 164, no. 2-4, p. 206-210. DOI
Nasrin, D., Moushumi, S.J., Ahmed, R., Nahar, N., Ahsan, S., Khatun, A., Jamal, F., Chowdhury, M.H., Rahmatullah, M. An evaluation of administration in diet of Saraca asoca (Roxb.) De Wilde bark extract on serum lipid profiles in rats. Advances in natural and applied sciences, 2010, vol. 4, no. 3, p. 382-384.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature